Treatment of ADHD With Atomoxetine in Children & Adolescents With ADHD & Comorbid Dyslexia

NCT00607919 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

209

Enrollment

INDUSTRY

Sponsor class

Conditions

Attention Deficit Hyperactivity Disorder
Dyslexia

Interventions

DRUG: Atomoxetine
DRUG: Placebo

Sponsor

Eli Lilly and Company